Australia's largest stock trading and investment forum Australia's #1 stock forum

CHP

0.00%

0.5¢ chapmans limited

CHP - COMPANY INFO, page-2

First 2 Last

Share
Profile

Follow
Jamesie05

1,510 Posts.

34

19/10/17

11:34

Post #: 28025820
Share

Originally posted by Dodgers ↑

shares on issue - 745,000,057
current cash position - $2.2 million TOTAL comprising of: $1million @ bank+ $700,000 from Digital4ge + $500,000 R & D grant received
current share price - .005
current market cap - $3.7 million

MJLS (49.9% ownership) is a massive investment for CHP with the right people in the right space - these same people who will be bringing it to market have also floated both ZLD & AC8, both with market caps that currently dwarf our own by a mile and we have a large stake directly into there next spin off on the market - history says it's a wonderful investment, they have another listing coming up and then MJLS will be next.

SynDynamics (80% ownership) has completed its advanced stages of licensing agreements with a large scale commercial customer on a 50/50 JV basis, who was announced as Total Waste Management (TWM). The CSIRO has already given the go ahead after 12 months of rigorous testing which is a massive milestone. 10,000+ tonnes per annum is serious coin.

20Four (39.25% ownership) has generated massive media attention, with an audience of over 15 million people through social media accounts, campaigns with high profile big brands that is already generating large revenue for 20Four. With a massive stake and an ASX listing imminent, CHP could be ready to make big $$ on there early investments in DSM. Backed by the $2 billion dollar Wilson family (owners of Reece Plumbing) CHP is in good hands here.

Chapmans new board member opens up a wealth of possibilities as well given his past experience, particularly as an industrialist. As quoted by Peter Dykes 'His experience as a large scale industrialist & extensive relationships with major private and institutional investors can be expected to add significant value to Chapmans Limited'

$2 million $$ recently raised strictly to Sophisticated investors - around 66%+ of the company is now owned by sophisticated investors and the 2 directors.

Catalysts for share price growth
- 20Four listing on the ASX
- MJLS listing on the ASX
- SynDynamics listing on the ASX and being fully commissioned

The company is capped at $3.7m market cap with $2.2m in cash and hefty positions in 20Four, MJLS & SynDynamics. It seems undervalued at this level regardless of the external noise attached to the directors of this company.

Both directors own massive chunks of this company and have indicated they are going to take up their FULL ENTITLEMENT in the upcoming rights issue - that is around $400,000 worth of stock between them.

With an EV of currently only $1.5m with some great assets that we are finally set to realise financially, this is well undervalued IMO.

Expand

The of share amount on offer you have listed is that before or after the current raise in shares, if not add 50% of shares on issues

CHP Price at posting: 0.5¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

There are more pages in this discussion • 38 more messages in this thread...

First 2 Last

Add CHP (ASX) to my watchlist

CHP - COMPANY INFO, page-2

Top Stories

BCI reaches close of funding facility for salt-first part of Mardie project

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News